Patent Applications
| Application Number | Title | Category | Assignee | Date Issued |
|---|---|---|---|---|
| 20090238805 | METHODS AND COMPOSITIONS FOR INCREASING RNA INTERFERENCE | DRUG | Devgen N.V. | 24-Sep-09 |
| 20090222952 | Plants Having Improved Growth Characteristics And A Method For Making The Same | MULTICELLULAR LIVING ORGANISMS | CropDesign N.V. | 3-Sep-09 |
Canada
| Application Number | Title | Category | Assignee | Date Issued |
|---|---|---|---|---|
| 20090239276 | GENETICALLY MODIFIED YEAST STRAIN | DRUG | GREENFIELD ETHANOL INC. | 24-Sep-09 |
| 20090226724 | MULTIFUNCTIONAL NANOSTRUCTURE AND METHOD | STOCK MATERIAL OR MISCELLANEOUS ARTICLES | NATIONAL RESEARCH COUNCIL OF CANADA | 10-Sep-09 |
Denmark
| Application Number | Title | Category | Assignee | Date Issued |
|---|---|---|---|---|
| 20090239756 | PREDICTORS FOR METASTASIS OF BREAST CANCER | COMBINATORIAL CHEMISTRY TECHNOLOGY | Syddansk Universitet | 24-Sep-09 |
France
| Application Number | Title | Category | Assignee | Date Issued |
|---|---|---|---|---|
| 20090226468 | Hybrid tetanus toxoid proteins that migrate retrogradely and transynaptically into the CNS | DRUG | Institut Pasteur | 10-Sep-09 |
| 20090239312 | Chromosome 6 and 9 Genes Involved in Premature Canities | DRUG | L'OREAL | 24-Sep-09 |
| 20090239934 | Anti-Myosin Va siRNA and Skin Depigmentation | DRUG | PIERRE FABRE DERMO-COSMETIQUE | 24-Sep-09 |
| 20090222937 | MEGANUCLEASE VARIANTS CLEAVING A DNA TARGET SEQUENCE FROM A XERODERMA PIGMENTOSUM GENE AND USES THEREOF | MULTICELLULAR LIVING ORGANISMS | CELLECTIS | 3-Sep-09 |
Germany
| Application Number | Title | Category | Assignee | Date Issued |
|---|---|---|---|---|
| 20090221043 | MUTANT OF THE PROB GENE FROM CORYNEFORM BACTERIA | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | DEGUSSA GmbH | 3-Sep-09 |
| 20090221027 | Use of a bacillus meti gene to improve methionine production in microorganisms | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | BASF AG | 3-Sep-09 |
| 20090221444 | Method for Identifying, Marking and Treating Epithelial Lung Tumour Cells and Means for Carrying Out Said Method | COMBINATORIAL CHEMISTRY TECHNOLOGY | Anqewandlen Forschung E.V. | 3-Sep-09 |
| 20090241227 | Expression cassettes for seed-preferential expression in plants | DATA PROCESSING | BASF Plant Science GmbH | 24-Sep-09 |
| 20090234006 | Method for Producing Arachidonic Acid and/or Eicosapentaenoic Acid in Useful Transgenic Plants | DRUG | Basf Plant Science GmbH | 17-Sep-09 |
| 20090220498 | Method for Discovering Inhibitors of the Epstein-Barr Virus-Induced Gene 3 (EBI3) and Derivatives Thereof for the Treatment of Metastasizing Tumors and Allergic Asthma | DRUG | Finotto; Susetta | 3-Sep-09 |
| 20090221674 | COMPOSITIONS AND METHODS FOR THERAPY AND DIAGNOSIS OF CANCER | DRUG | GANYMED PHARMACEUTICALS AG | 3-Sep-09 |
| 20090241230 | Expression cassettes for seed-preferential expression in plants | MULTICELLULAR LIVING ORGANISMS | BASF Plant Science GmbH | 24-Sep-09 |
India
| Application Number | Title | Category | Assignee | Date Issued |
|---|---|---|---|---|
| 20090221682 | DNA Vaccine for Cancer Therapy | DRUG | Maithal; Kapil | 3-Sep-09 |
| 20090220520 | Recombinant method for the production of a monoclonal antibody to CD52 for the treatment of chronic lymphocytic leukemia | DRUG | Patell; Villoo Morawala | 3-Sep-09 |
Israel
| Application Number | Title | Category | Assignee | Date Issued |
|---|---|---|---|---|
| 20090226909 | Methods and kits for Determining Predisposition to Warfarin Resistance | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | Tel HaShomer Medical Research Infrastructure and Services Ltd. | 10-Sep-09 |
Japan
| Application Number | Title | Category | Assignee | Date Issued |
|---|---|---|---|---|
| 20090220967 | Systemic Carnitine Deficiency Gene and Uses Thereof | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | CHUGAI SEIYAKU KABUSHIKI KAISHA | 3-Sep-09 |
| 20090226936 | Tetrahydrofolate Synthetase Gene | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | DAIICHI PHARMACEUTICAL CO., LTD. | 10-Sep-09 |
| 20090233366 | COMPOSITION FOR INTRODUCTION OF NUCLEIC ACID | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | DAIICHI SANKYO COMPANY, LIMITED | 17-Sep-09 |
| 20090226961 | MUTANT ALPHA-AMYLASES | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | Endo; Keiji | 10-Sep-09 |
| 20090226901 | Method of evaluating or selecting agents for preventing or improving pigmented spots | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | Kao Corporation | 10-Sep-09 |
| 20090221055 | Novel Bacillus Subtilis Mutant Strain | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | Kao Corporation; and Nara Institute of Science and Technology | 3-Sep-09 |
| 20090221045 | METHOD FOR PRODUCING HYDROXYCARBOXYLIC ACID BY ENHANCING SYNTHESIS OF COENZYME | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | MITSUI CHEMICALS, INC. | 3-Sep-09 |
| 20090220976 | Test Method for MALT Lymphomas and Kit Therefor | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY | 3-Sep-09 |
| 20090233320 | GENE ENCODING NOVEL LUCIFERASE | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | NEC Soft, Ltd. | 17-Sep-09 |
| 20090226984 | L-CYSTEINE PRODUCING BACTERIUM AND A METHOD FOR PRODUCING L-CYSTEINE | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | Nonaka; Gen | 10-Sep-09 |
| 20090226983 | L-CYSTEINE-PRODUCING BACTERIUM AND A METHOD FOR PRODUCING L-CYSTEINE | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | Nonaka; Gen | 10-Sep-09 |
| 20090221065 | COMPOSITION FOR SUPPRESSING THE EXPRESSION OF FUCOSYLTRANSFERASE | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | OSAKA UNIVERSITY | 3-Sep-09 |
| 20090233278 | Branched-chain amino acid aminotransferase gene and use thereof | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | SUNTORY LIMITED | 17-Sep-09 |
| 20090220960 | LUCIFERASE GENE OPTIMIZED FOR USE IN IMAGING OF INTRACELLULAR LUMINESCENCE | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | TOYO BOSEKI KABUSHIKI KAISHA | 3-Sep-09 |
| 20090226918 | Gene overexpressed in cancer | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | ABURATANI; Hiroyuki | 10-Sep-09 |
| 20090226982 | L-CYSTEINE PRODUCING MICROORGANISM AND METHOD FOR PRODUCING L-CYSTEINE | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | AJINOMOTO CO., INC | 10-Sep-09 |
| 20090233288 | PRIMER SET FOR GENE AMPLIFICATION, REAGENT FOR GENE AMPLIFICATION INCLUDING THE SAME, AND USES THEREOF | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | ARKRAY, Inc. | 17-Sep-09 |
| 20090239239 | EUKARYOTIC AMADORIASE HAVING EXCELLENT THERMAL STABILITY, GENE AND RECOMBINANT DNA FOR THE EUKARYOTIC AMADORIASE, AND PROCESS FOR PRODUCTION OF EUKARYOTIC AMADORIASE HAVING EXCELLENT THERMAL STABILITY | DRUG | Hirokawa; Kozo; | 24-Sep-09 |
| 20090232773 | Method for Distinguishing Mesenchymal Stem Cell Using Molecular Marker and Use Thereof | DRUG | Kato; Yukio | 17-Sep-09 |
| 20090233987 | Method and apparatus for drug delivery to tissue or organ for transplant | DRUG | Keio University | 17-Sep-09 |
| 20090226399 | MEDICAMENTS COMPRISING GENE RECOMBINANT ANTIBODY AGAINST GANGLIOSIDE GD3 | DRUG | KYOWA HAKKO KIRIN CO., LTD. | 10-Sep-09 |
| 20090239227 | Method of diagnosing risk of myocardial infarction | DRUG | Nagoya Industrial Science Research Institute | 24-Sep-09 |
| 20090220512 | GENES AND POLYPEPTIDES RELATING TO PROSTATE CANCERS | DRUG | Oncotherapy Science, Inc. | 3-Sep-09 |
| 20090239274 | Yeast and Method of Producing L-Lactic Acid | DRUG | Sawai; Hideki | 24-Sep-09 |
| 20090232771 | Method of controlling cell functions | DRUG | Takeda Pharmaceutical Company Limited | 17-Sep-09 |
| 20090222953 | MUTATED PLANT AND METHOD FOR PRODUCTION THEREOF | MULTICELLULAR LIVING ORGANISMS | RIKEN | 3-Sep-09 |
| 20090229011 | DISEASE-RESISTANT PLANTS AND METHOD OF CONSTRUCTING THE SAME | MULTICELLULAR LIVING ORGANISMS | TAKAKURA; Yoshimitsu | 10-Sep-09 |
| 20090234271 | COMPOSITION COMPRISING siRNA-POLYCATION COMPLEX FOR IONTOPHORESIS | SURGERY | Kajimoto; Kazuaki | 17-Sep-09 |
Korea
| Application Number | Title | Category | Assignee | Date Issued |
|---|---|---|---|---|
| 20090220963 | KIT SUITABLE FOR SCREENING AND ESTABLISMENT OF OPTIMAL AMPLIFICATION CONDITION IN PCR CONSTRUCTED WITH DRIED-FORMULATED PCR REAGENT AND METHOD FOR PRODUCING THE SAME | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | iNtRON Biotechnology, Inc. | 3-Sep-09 |
| 20090226964 | Polymyxin Synthetase and Gene Cluster Thereof | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | Korea Research Instituteof Bioscience and Biotechnology | 10-Sep-09 |
| 20090227777 | Monoclonal antibody for hippuric acid antigen | NATURAL RESINS OR DERIVATIVES | Tae; Gun Sik | 10-Sep-09 |
Netherlands
| Application Number | Title | Category | Assignee | Date Issued |
|---|---|---|---|---|
| 20090226902 | Method to Diagnose or Screen for Inflammatory Diseases | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | Drexhage; Hemmo Arjan | 10-Sep-09 |
| 20090226885 | Nucleic Acid Sequences That Can Be Used As Primers And Probes In The Amplification And Detection Of Sars Coronavirus | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | Sillekens; P.T.G | 10-Sep-09 |
| 20090233287 | PRODUCTION OF COMPOUNDS IN A RECOMBINANT HOST | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | Bovenberg; Roelof Ary Lans | 17-Sep-09 |
| 20090227505 | Methods and uses for protein breakdown products | DRUG | Biotempt B.V. | 10-Sep-09 |
| 20090220539 | Recombinant Mononegaviral Virus Vectors | DRUG | Inervet International B.V. | 3-Sep-09 |
| 20090232846 | Pestivirus mutant for use in a vaccine | DRUG | Intervet International B.V. | 17-Sep-09 |
| 20090232936 | Novel lipases and uses thereof | FOOD OR EDIBLE MATERIAL | DSM IP ASSETS B.V. | 17-Sep-09 |
Norway
| Application Number | Title | Category | Assignee | Date Issued |
|---|---|---|---|---|
| 20090226904 | DIAGNOSIS AND TREATMENT OF EXOCRINE PANCREATIC DYSFUNCTION AND DIABETES | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | University of Bergen | 10-Sep-09 |
| 20090235367 | Non-human mammal comprising a modified SERCA2 gene and methods, cells, genes, and vectors thereof | MULTICELLULAR LIVING ORGANISMS | Christensen; Geir | 17-Sep-09 |
| 20090235371 | Diagnostic method | MULTICELLULAR LIVING ORGANISMS | Lingaas; Frode | 17-Sep-09 |
Sweden
| Application Number | Title | Category | Assignee | Date Issued |
|---|---|---|---|---|
| 20090227559 | SNPS IN THE APOB GENE AND SUSCEPTIBILITY TO INCREASED LEVELS OF ALAT FOLLOWING XIMELAGATRAN ADMINISTRATION | DRUG | AstraZeneca AB | 10-Sep-09 |
Switzerland
| Application Number | Title | Category | Assignee | Date Issued |
|---|---|---|---|---|
| 20090227470 | SELECTION OF BIOCATALYSTS FOR CHEMICAL SYNTHESIS | COMBINATORIAL CHEMISTRY TECHNOLOGY | Witholt; Bernard | 10-Sep-09 |
| 20090239908 | METHODS OF TREATING PSYCHOSIS AND SCHIZOPHRENIA BASED ON POLYMORPHISMS IN THE CNTF GENE | DRUG | Novartis AG | 24-Sep-09 |
| 20090222936 | Recombinant Expression of Multiprotein Complexes Using Polygenes | MULTICELLULAR LIVING ORGANISMS | Richmond; Timothy | 3-Sep-09 |
United Kingdom
| Application Number | Title | Category | Assignee | Date Issued |
|---|---|---|---|---|
| 20090226992 | Enhancement of Microbial Ethanol Production | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | Bioconversion Technologies Limited | 10-Sep-09 |
| 20090241207 | Expression of heterologous genes according to a targeted expression profile | DATA PROCESSING | Lathe; Richard | 24-Sep-09 |
| 20090239247 | MN and Hypoxia | DRUG | Harris; Adrian L. | 24-Sep-09 |
United States
| Application Number | Title | Category | Assignee | Date Issued |
|---|---|---|---|---|
| 20090233379 | Taste Receptors Of The T1R Family From Domestic Dog | CHEMISTRY: ANALYTICAL AND IMMUNOLOGICAL TESTING | Monell Chemical Senses Center | 17-Sep-09 |
| 20090227011 | METHODS OF PURIFYING PLASMID DNA | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | Chen; Shizhong | 10-Sep-09 |
| 20090239797 | PRODUCTION OF HIGH LEVELS OF TRANSGENIC FACTOR IX WITHOUT GENE RESCUE, AND ITS THERAPEUTIC USES | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | COOPER; Julian D.; | 24-Sep-09 |
| 20090221078 | ZYMOMONAS WITH IMPROVED ETHANOL PRODUCTION IN MEDIUM CONTAINING CONCENTRATED SUGARS AND ACETATE | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | E.I. DU PONT DE NEMOURS AND COMPANY | 3-Sep-09 |
| 20090233299 | Physiogenomic Method for Predicting Statin Injury to Muscle and Muscle Side Effects | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | GENOMAS, INC. | 17-Sep-09 |
| 20090226991 | YEAST ORGANISM PRODUCING ISOBUTANOL AT A HIGH YIELD | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | GEVO, INC. | 10-Sep-09 |
| 20090226981 | L-Glutamic Acid-Producing Microorganism and a Method for Producing L-Glutamic Acid | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | Hara; Yoshihiko | 10-Sep-09 |
| 20090226915 | Methods for Screening, Predicting and Monitoring Prostate Cancer | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | HEALTH DISCOVERY CORPORATION | 10-Sep-09 |
| 20090220956 | Prediction of Local Recurrence of Breast Cancer | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | Nuyten; Dimitry Serge Antoine | 3-Sep-09 |
| 20090220970 | MOLECULAR TOXICOLOGY MODELING | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | Ocimum Biosolutions, Inc. | 3-Sep-09 |
| 20090226976 | METHODS FOR DYNAMIC VECTOR ASSEMBLY OF DNA CLONING VECTOR PLASMIDS | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | Reed; Thomas D.; | 10-Sep-09 |
| 20090239769 | Expression Miniarrays and Uses Thereof | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | Shafer; David A.; | 24-Sep-09 |
| 20090233279 | Methods and Compositions for Predicting Death from Cancer and Prostate Cancer Survival Using Gene Expression Signatures | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | Sidney Kimmel Cancer Center | 17-Sep-09 |
| 20090233270 | Secreted and cytoplasmic tumor endothelial markers | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | St. Croix; Brad | 17-Sep-09 |
| 20090220971 | Treatment Response in Generalized Social Phobia | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | Stein; Murray B. | 3-Sep-09 |
| 20090226989 | Genetically modified yeast of the species issatchenkia orientalis and closely relates species, and fermentation processes using same | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | Suominen; Pirkko | 10-Sep-09 |
| 20090227028 | BIOLOGICAL CONTROL OF PATHOGENICITY IN MICROBES THAT USE ALPHA, BETA UNSATURATED FATTY ACID SIGNAL MOLECULES | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 10-Sep-09 |
| 20090233298 | FIG4 GENE MUTATIONS IN NEURODEGENERATION | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 17-Sep-09 |
| 20090226933 | QUANTIFICATION OF FUSION PROTEINS AND THEIR ACTIVITY FROM CHROMOSOMAL TRANSLOCATION | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | University of Texas M.D. Anderson Cancer Center | 10-Sep-09 |
| 20090226923 | COMPOSITIONS AND METHODS OF USE OF STANDARDIZED MIXTURES | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | University of Toledo | 10-Sep-09 |
| 20090233365 | ARGININE-CONJUGATED BIOREDUCIBLE POLY(DISULFIDE AMINE) POLYMERS FOR GENE DELIVERY SYSTEMS | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | University of Utah Research Foundation | 17-Sep-09 |
| 20090226921 | METHODS TO DETECT TUMORS USING 20P1F12/TMPRSS2 EXPRESSION | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | AFAR; Daniel E. H. | 10-Sep-09 |
| 20090226968 | Engineering Intracellular Sialylation Pathways | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | Betenbaugh; Michael J. | 10-Sep-09 |
| 20090226959 | Production of modified glycoproteins having multiple antennary structures | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | Bobrowicz; Piotr | 10-Sep-09 |
| 20090220972 | Probe, Probe Set, Probe-Immobilized Carrier, and Genetic Testing Method | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | CANON KABUSHIKI KAISHA | 3-Sep-09 |
| 20090226889 | METHODS AND COMPOSITIONS FOR DETECTING CNS VIRUSES | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | Chen; Fan | 10-Sep-09 |
| 20090221440 | METHODS AND COMPOSITIONS RELATED TO IDENTIFYING PROTEIN-PROTEIN INTERACTIONS | COMBINATORIAL CHEMISTRY TECHNOLOGY | Board of Regents, the University of Texas System | 3-Sep-09 |
| 20090227469 | CELLS AND ASSAYS FOR USE IN DETECTING LONG QT SYNDROME | COMBINATORIAL CHEMISTRY TECHNOLOGY | Conklin; Bruce R. | 10-Sep-09 |
| 20090233803 | CHROMOGENIC IN SITU HYBRIDIZATION METHODS, KITS, AND COMPOSITIONS | COMBINATORIAL CHEMISTRY TECHNOLOGY | INVITROGEN CORPORATION | 17-Sep-09 |
| 20090221445 | Cancer Diagnostic Panel | COMBINATORIAL CHEMISTRY TECHNOLOGY | Wang; Yixin | 3-Sep-09 |
| 20090241220 | Nucleic Acid Molecules and Other Molecules Associated with Plants | DATA PROCESSING | ABAD; MARK S.; | 24-Sep-09 |
| 20090241229 | NUCLEIC ACID MOLECULES AND OTHER MOLECULES ASSOCIATED WITH PLANTS | DATA PROCESSING | ANDERSEN; SCOTT E. | 24-Sep-09 |
| 20090241228 | Nucleic Acid Molecules and Other Molecules Associated with Plants | DATA PROCESSING | ANDERSEN; SCOTT E. | 24-Sep-09 |
| 20090228319 | Breed-Specific Haplotypes for Polled Phenotypes in Cattle | DATA PROCESSING | Gill; Clare A.; | 10-Sep-09 |
| 20090241206 | METHODS FOR CLONING FERRETS AND TRANSGENIC FERRET MODELS FOR DISEASES | DATA PROCESSING | University of Iowa Research Foundation | 24-Sep-09 |
| 20090232797 | PLASMODIUM MALARIAE AND PLASMODIUM OVALE GENES AND USES THEREOF | DRUG | ABBOTT LABORATORIES | 17-Sep-09 |
| 20090226445 | PLASMODIUM MALARIAE AND PLASMODIUM OVALE GENES AND USES THEREOF | DRUG | ABBOTT LABORATORIES | 10-Sep-09 |
| 20090232893 | miR-143 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION | DRUG | Bader; Andreas G. | 17-Sep-09 |
| 20090227533 | miR-34 Regulated Genes and Pathways as Targets for Therapeutic Intervention | DRUG | Bader; Andreas G.; | 10-Sep-09 |
| 20090233848 | Pea15 as a Tumor Suppressor Gene | DRUG | Bartholomeusz; Chandra | 17-Sep-09 |
| 20090232813 | Four-Jointed Box (FJX1) In Cancer Diagnosis and Treatment | DRUG | Beauchamp; R. Daniel | 17-Sep-09 |
| 20090239937 | Apoptosis-Inducing Genes for Treating Cancer | DRUG | Caldas; Hugo | 24-Sep-09 |
| 20090221493 | OCL-2A3 COMPOSITIONS AND USES THEREOF | DRUG | CHOI; YONGWON | 3-Sep-09 |
| 20090239225 | PREDICTION AND DIAGNOSIS OF CANINE DEGENERATIVE MYELOPATHY | DRUG | Coates; Joan R | 24-Sep-09 |
| 20090226459 | ROLE OF FGF-19 IN CANCER DIAGNOSIS AND TREATMENT | DRUG | COLD SPRING HARBOR LABORATORY | 10-Sep-09 |
| 20090226405 | COMPOSITIONS AND METHODS TO TREAT CANCER WITH CUPREDOXINS AND CpG RICH DNA | DRUG | Das Gupta; Tapas | 10-Sep-09 |
| 20090220495 | Cancer Related Genes (PRLR) | DRUG | Fanidi; Abdallah | 3-Sep-09 |
| 20090220488 | EVALUATING AND TREATING SCLERODERMA | DRUG | Gardner; Humphrey | 3-Sep-09 |
| 20090239236 | GENE DETECTION ASSAY FOR IMPROVING THE LIKELIHOOD OF AN EFFECTIVE RESPONSE TO AN EGFR ANTAGONIST CANCER THERAPY | DRUG | Genentech, Inc. | 24-Sep-09 |
| 20090232814 | Cancer biomarker genes and gene products and methods for using the same | DRUG | Goldberg; Gary S. | 17-Sep-09 |
| 20090220584 | Amphoteric Liposome Formulation | DRUG | Goodwin; Neal Clifford | 3-Sep-09 |
| 20090239266 | Method for Producing a Non-Aromatic L-Amino Acid Using a Bacterium of the Enterobacteriaceae Family Having Expression of the csrA Gene Attenuated | DRUG | Gulevich; Andrey Yurievich | 24-Sep-09 |
| 20090226420 | Methods of Determining the Risk of Developing Coronary Artery Disease | DRUG | Hauser; Elizabeth | 10-Sep-09 |
| 20090227657 | COMPOSITION AND METHODS OF RNAi THERAPEUTICS FOR TREATMENT OF CANCER AND OTHER NEOVASCULARIZATION DISEASES | DRUG | Intradigm Corporation | 10-Sep-09 |
| 20090239938 | PREVENTIVE/REMEDY FOR ARTERIOSCLEROSIS | DRUG | JAPAN SCIENCE AND TECHNOLOGY AGENCY | 24-Sep-09 |
| 20090227489 | STAT3 Agonists and Antagonists and Therapeutic Uses Thereof | DRUG | Johns Hopkins University | 10-Sep-09 |
| 20090220510 | Specific binding proteins and uses thereof | DRUG | Ludwig Institute for Cancer Research | 3-Sep-09 |
| 20090220481 | METHOD AND COMPOSITIONS FOR TREATING SKIN | DRUG | MAES; DANIEL H. | 3-Sep-09 |
| 20090232780 | COMPOUNDS THAT ENHANCE ATOH1 EXPRESSION | DRUG | Massachusetts Eye & Ear Infirmary | 17-Sep-09 |
| 20090226451 | Novel 18636, 2466, 43238, 1983, 52881, 2398, 45449, 50289, 52872 and 26908 molecules and uses therefor | DRUG | Millennium Pharmaceuticals, Inc. | 10-Sep-09 |
| 20090226450 | Novel 15571, 2465, 14266, 2882, 52871, 8203 and 16852 molecules and uses therefor | DRUG | Millennium Pharmaceuticals, Inc. | 10-Sep-09 |
| 20090226449 | Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921, and 33751 molecules and uses therefor | DRUG | Millennium Pharmaceuticals, Inc. | 10-Sep-09 |
| 20090226448 | Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 and 33751 molecules and uses therefor | DRUG | Millennium Pharmaceuticals, Inc. | 10-Sep-09 |
| 20090233986 | Methods and compositions for using sax2 | DRUG | MOUNT SINAI SCHOOL OF MEDICINE | 17-Sep-09 |
| 20090226499 | BIOCOMPATIBLE MATERIALS CONTAINING STABLE COMPLEXES OF TSG-6 AND HYALURONAN AND METHOD OF USING SAME | DRUG | NEW YORK UNIVERSITY | 10-Sep-09 |
| 20090239232 | METHODS OF RNA AMPLIFICATION IN THE PRESENCE OF DNA | DRUG | NuGEN Technologies Inc | 24-Sep-09 |
| 20090221673 | Compositions and Methods for Regulating RNA Translation via CD154 CA-Dinucleotide Repeat | DRUG | Rigby; William F. C. | 3-Sep-09 |
| 20090220458 | PSEUDOTYPED RETROVIRAL VECTORS AND METHODS OF USE THEREOF | DRUG | Schaffer; David V. | 3-Sep-09 |
| 20090233983 | RNA Interference Mediated Inhibition of Protein Tyrosine Phosphatase-1B (PTP-1B) Gene Expression Using Short Interfering RNA | DRUG | SIRNA THERAPEUTICS INC. | 17-Sep-09 |
| 20090239931 | RNA INTERFERENCE MEDIATED INHIBITION OF PROTEIN TYROSINE PHOSPHATASE-1B (PTP-1B) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) | DRUG | Sirna Therapeutics, Inc. | 24-Sep-09 |
| 20090226521 | Active nanoparticles and method of using | DRUG | STC . UNM | 10-Sep-09 |
| 20090220507 | INHIBITION OF EXTRACELLULAR SIGNAL-REGULATED KINASE 1/2 AS A TREATMENT FOR CARDIAC HYPERTROPHY AND HEART FAILURE | DRUG | Sucharov; Carmen C. | 3-Sep-09 |
| 20090220569 | Prevascularized Constructs for Implantation to Provide Blood Perfusion | DRUG | The Arizona Board of Regents on behalf of the University of Arizona | 3-Sep-09 |
| 20090239220 | DLC-1 GENE DELETED IN CANCERS | DRUG | The Government of the United States of America as Represented by the Secretary of the Department of Health and Human Services | 24-Sep-09 |
| 20090227664 | Expression Vectors Able to Elicit Improved Immune Response and Methods of Using Same | DRUG | The Government of the United States of America as Represented by the Secretary of the Rockville | 10-Sep-09 |
| 20090221522 | METHODS TO CORRECT GENE SET EXPRESSION PROFILES TO DRUG SENSITIVITY | DRUG | The Johns Hopkins University | 3-Sep-09 |
| 20090239221 | RECURRENT GENE FUSIONS IN PROSTATE CANCER | DRUG | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 24-Sep-09 |
| 20090220503 | METHOD FOR TREATING CANCERS WITH INCREASED RAS SIGNALING | DRUG | THE TRUSTEES OF BOSTON UNIVERSITY | 3-Sep-09 |
| 20090232819 | METHOD USING SNAIL TRANSCRIPTIONAL REPRESSOR | DRUG | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 17-Sep-09 |
| 20090221684 | Molecules for Gene Delivery and Gene Therapy, and Methods of Use Thereof | DRUG | Trustees of Boston University | 3-Sep-09 |
| 20090226528 | ENCAPSULATED NANOPARTICLES FOR NUCLEIC ACID DELIVERY | DRUG | UNIVERSITY OF MASSACHUSETTS | 10-Sep-09 |
| 20090220511 | Ifn-alpha/beta-independent mechanism of antiviral protection through a novel ligand-receptor pair: Ifn- ligands engage a novel receptor Ifn-Rn (CRF2-12) and IL-10R2 (CRF2-4) for signaling andinduction of biological activities | DRUG | UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY | 3-Sep-09 |
| 20090221492 | EXPRESSION OF ACTIVE HUMAN FACTOR IX IN MAMMARY TISSUE OF TRANSGENIC ANIMALS | DRUG | Velander; William H. | 3-Sep-09 |
| 20090239305 | Gene recombination exchange system for stable gene modification in human ES cells | DRUG | Zhang; Su-Chun | 24-Sep-09 |
| 20090235395 | USE OF MIXED DUPLEX OLIGONUCLEOTIDES TO EFFECT LOCALIZED GENETIC CHANGES IN PLANTS | MULTICELLULAR LIVING ORGANISMS | Arntzen; Charles J. | 17-Sep-09 |
| 20090222945 | Brittle stalk 2 polynucleotides, polypeptides, and uses thereof | MULTICELLULAR LIVING ORGANISMS | Ching; Ada S. | 3-Sep-09 |
| 20090228995 | Polymorphisms and Haplotypes of the Alpha 2C Adrenergic Receptor Gene | MULTICELLULAR LIVING ORGANISMS | Liggett; Stephen Bryant | 10-Sep-09 |
| 20090229015 | Schizochytrium Fatty Acid Synthase (FAS) and Products and Methods Related Thereto | MULTICELLULAR LIVING ORGANISMS | MARTEK BIOSCIENCES CORPORATION | 10-Sep-09 |
| 20090222954 | Maize Genes For Controlling Plant Growth and Organ Size and Their Use in Improving Crop Plants | MULTICELLULAR LIVING ORGANISMS | PIONEER HI-BRED INTERNATIONAL, INC. | 3-Sep-09 |
| 20090229007 | Oleosin Genes and Promoters From Coffee | MULTICELLULAR LIVING ORGANISMS | Tanksley; Steven D. | 10-Sep-09 |
| 20090222934 | Pre-B Cell Proliferation and Lymphoblastic Leukemia/High-Grade Lymphoma in MIR155 Transgenic Mice | MULTICELLULAR LIVING ORGANISMS | THE OHIO STATE UNIVERSITY | 3-Sep-09 |
| 20090234101 | DIRECTED EVOLUTION OF NOVEL BINDING PROTEINS | NATURAL RESINS OR DERIVATIVES | DYAX CORP. | 17-Sep-09 |
| 20090227780 | siRNA targeting connexin 43 | ORGANIC COMPOUNDS | DHARMACON, INC. | 10-Sep-09 |
Login
Advertisements
Dayal Resources, Inc.
Translations from German to English, including patents, research papers, legalese and materials for publication. Dayal Resources, Inc. is your dependable resource. Please contact wdayal@dayalresources.com
Translations from German to English, including patents, research papers, legalese and materials for publication. Dayal Resources, Inc. is your dependable resource. Please contact wdayal@dayalresources.com
Eden's Bounty Multi-SanTM
Colorless, odorless, biodegradable instant sanitizer is effective against both gram positive and gram-negative bacteria; kills in 30 seconds. Free of chlorine and quaternary ammonium compounds. EPA registered food contact surface sanitizer. Austin Davis Industries, Inc.
Colorless, odorless, biodegradable instant sanitizer is effective against both gram positive and gram-negative bacteria; kills in 30 seconds. Free of chlorine and quaternary ammonium compounds. EPA registered food contact surface sanitizer. Austin Davis Industries, Inc.
TERRA+ CLEAN Acid-Replacement Surface Cleaner
Safe, totally natural, 100% biodegradable, multi-functional cleaning product providing safety in the workplace for both humans and environmental surfaces - without compromising performance. Can be diluted up to 25:1. Austin Davis Industries, Inc.
Safe, totally natural, 100% biodegradable, multi-functional cleaning product providing safety in the workplace for both humans and environmental surfaces - without compromising performance. Can be diluted up to 25:1. Austin Davis Industries, Inc.





